Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca PiccoliHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandYoung‐Jun ParkDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USAM. Alejandra TortoriciDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institut Pasteur and CNRS UMR 3569, Unité de Virologie Structurale, 75015 Paris, FranceNadine CzudnochowskiVir Biotechnology, San Francisco, CA 94158, USAAlexandra C. WallsDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USAMartina BeltramelloHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandChiara Silacci-FregniHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandDora PintoHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandLaura E. RosenVir Biotechnology, San Francisco, CA 94158, USAJohn E. BowenDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USAOliver J. ActonDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USAStefano JaconiHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandBarbara GuarinoHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandAndrea MinolaHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandFabrizia ZattaHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandNicole SprugasciHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandJessica BassiHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandAlessia PeterHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandAnna De MarcoHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandJay C. NixMolecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USAFederico MeleInstitute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, SwitzerlandSandra JovicInstitute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, SwitzerlandBlanca Fernandez RodriguezInstitute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, SwitzerlandSneha GuptaVir Biotechnology, San Francisco, CA 94158, USAFeng JinVir Biotechnology, San Francisco, CA 94158, USAGiovanni PiumattiDivision of Primary Care, Geneva University Hospitals, 1205 Geneva, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, SwitzerlandGiorgia Lo PrestiClinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, SwitzerlandAlessandra Franzetti-PellandaClinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, SwitzerlandMaira BiggiogeroClinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, SwitzerlandMaciej TarkowskiIII Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, ItalyMatteo Samuele PizzutoHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandElisabetta CameroniHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandColin Havenar‐DaughtonVir Biotechnology, San Francisco, CA 94158, USAMegan J. SmitheyVir Biotechnology, San Francisco, CA 94158, USADavid K. HongVir Biotechnology, San Francisco, CA 94158, USAValentino LeporiEmiliano AlbaneseInstitute of Public Health, Università della Svizzera italiana, 6900 Lugano, SwitzerlandAlessandro CeschiFaculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, SwitzerlandEnos BernasconiDivision of Infectious Diseases, Ente Ospedaliero Cantonale, Ospedale Civico and Ospedale Italiano, 6900 Lugano, SwitzerlandLuigia ElziDivision of Infectious Diseases, Ente Ospedaliero Cantonale, Ospedale Regionale Bellinzona e Valli and Ospedale Regionale, 6600 Locarno, SwitzerlandPaolo FerrariDepartment of Nephrology, Ospedale Civico Lugano, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, NSW 2052, AustraliaChristian GarzoniClinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, SwitzerlandAgostino RivaIII Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, ItalyGyorgy SnellVir Biotechnology, San Francisco, CA 94158, USAFederica SallustoInstitute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, SwitzerlandKatja FinkHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandHerbert W. VirginVir Biotechnology, San Francisco, CA 94158, USAAntonio LanzavecchiaHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, SwitzerlandDavide CortiHumabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: [email protected]David VeeslerDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USA. Electronic address: [email protected]
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0